Groundbreaking trial could spare thousands of breast cancer patients from unnecessary surgery
Disease control
Ongoing
This study looks at whether women with aggressive breast cancers (triple-negative or HER2-positive) who have a complete response to chemotherapy can safely avoid sentinel lymph node biopsy. The trial will enroll 350 patients across Europe, all of whom will have breast-conserving …
Phase: NA • Sponsor: Toralf Reimer, MD PhD • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC